Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells. / Eriksen, Karsten Wessel; Sommer, Viveca Horst; Woetmann, Anders; Rasmussen, Anette Bødker; Brender, Christine; Svejgaard, Arne; Skov, Søren; Geisler, Carsten; Ødum, Niels.

In: Journal of Biological Chemistry, Vol. 279, No. 1, 2003, p. 169-76.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Eriksen, KW, Sommer, VH, Woetmann, A, Rasmussen, AB, Brender, C, Svejgaard, A, Skov, S, Geisler, C & Ødum, N 2003, 'Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells', Journal of Biological Chemistry, vol. 279, no. 1, pp. 169-76. https://doi.org/10.1074/jbc.M310472200

APA

Eriksen, K. W., Sommer, V. H., Woetmann, A., Rasmussen, A. B., Brender, C., Svejgaard, A., Skov, S., Geisler, C., & Ødum, N. (2003). Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells. Journal of Biological Chemistry, 279(1), 169-76. https://doi.org/10.1074/jbc.M310472200

Vancouver

Eriksen KW, Sommer VH, Woetmann A, Rasmussen AB, Brender C, Svejgaard A et al. Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells. Journal of Biological Chemistry. 2003;279(1):169-76. https://doi.org/10.1074/jbc.M310472200

Author

Eriksen, Karsten Wessel ; Sommer, Viveca Horst ; Woetmann, Anders ; Rasmussen, Anette Bødker ; Brender, Christine ; Svejgaard, Arne ; Skov, Søren ; Geisler, Carsten ; Ødum, Niels. / Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells. In: Journal of Biological Chemistry. 2003 ; Vol. 279, No. 1. pp. 169-76.

Bibtex

@article{212a9e40b0a011ddb538000ea68e967b,
title = "Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells",
abstract = "Interferon (IFN)-alpha/beta is produced by virally infected cells and is believed to play an important role in early phases of the innate immune response. In addition, IFN-alpha/beta inhibits interleukin (IL)-4 signaling in B cells and monocytes, suggesting that IFN-alpha/beta (like IFN-gamma) is a Th1 cytokine. Here, we study cross-talk between IFN-alpha and IL-4 in human T cells. As expected, stimulation with IFN-alpha for 12-24 h inhibits IL-4 signaling. Surprisingly, however, IFN-alpha has the opposite effect on IL-4 signaling at earlier time points (up to 6 h). Thus, IFN-alpha enhances IL-4-mediated STAT6 activation in both CD4+ and CD8+ human T cells. The effect is specific because (i) another interferon, IFN-gamma, does not enhance IL-4-mediated STAT6 activation, (ii) IFN-alpha-mediated STAT1 and STAT2 activation is not modulated by IL-4, and (iii) activation of Janus kinases is not enhanced or prolonged by simultaneous stimulation with IFN-alpha and IL-4. Moreover, co-stimulation results in a selective increased STAT6/STAT2 association and an association between IFNAR/IL-4R components, suggesting that the IFNAR provides an additional STAT6 docking site via STAT2, leading to a more efficient dimerization/activation of STAT6 only. The co-stimulatory effect on STAT6 activation correlates with a cooperative increase in nuclear translocation, DNA binding, transcriptional activity, and mRNA expression of STAT6 target genes (IL-4Ralpha and IL-15Ralpha). In conclusion, we provide evidence that IFN-alpha both up- and down-regulates IL-4-mediated STAT6 signaling and thereby regulates the sensitivity to IL-4 in human T lymphocytes. Thus, our findings suggest that IFN-alpha has a complex regulatory role in adaptive immunity, which is different from the {"}classical{"} Th1 profile of IFN-gamma.",
author = "Eriksen, {Karsten Wessel} and Sommer, {Viveca Horst} and Anders Woetmann and Rasmussen, {Anette B{\o}dker} and Christine Brender and Arne Svejgaard and S{\o}ren Skov and Carsten Geisler and Niels {\O}dum",
note = "Keywords: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; DNA-Binding Proteins; Humans; Interferon Type I, Recombinant; Interleukin-4; Models, Immunological; STAT1 Transcription Factor; STAT2 Transcription Factor; STAT6 Transcription Factor; Signal Transduction; T-Lymphocytes; Trans-Activators",
year = "2003",
doi = "10.1074/jbc.M310472200",
language = "English",
volume = "279",
pages = "169--76",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology, Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells

AU - Eriksen, Karsten Wessel

AU - Sommer, Viveca Horst

AU - Woetmann, Anders

AU - Rasmussen, Anette Bødker

AU - Brender, Christine

AU - Svejgaard, Arne

AU - Skov, Søren

AU - Geisler, Carsten

AU - Ødum, Niels

N1 - Keywords: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; DNA-Binding Proteins; Humans; Interferon Type I, Recombinant; Interleukin-4; Models, Immunological; STAT1 Transcription Factor; STAT2 Transcription Factor; STAT6 Transcription Factor; Signal Transduction; T-Lymphocytes; Trans-Activators

PY - 2003

Y1 - 2003

N2 - Interferon (IFN)-alpha/beta is produced by virally infected cells and is believed to play an important role in early phases of the innate immune response. In addition, IFN-alpha/beta inhibits interleukin (IL)-4 signaling in B cells and monocytes, suggesting that IFN-alpha/beta (like IFN-gamma) is a Th1 cytokine. Here, we study cross-talk between IFN-alpha and IL-4 in human T cells. As expected, stimulation with IFN-alpha for 12-24 h inhibits IL-4 signaling. Surprisingly, however, IFN-alpha has the opposite effect on IL-4 signaling at earlier time points (up to 6 h). Thus, IFN-alpha enhances IL-4-mediated STAT6 activation in both CD4+ and CD8+ human T cells. The effect is specific because (i) another interferon, IFN-gamma, does not enhance IL-4-mediated STAT6 activation, (ii) IFN-alpha-mediated STAT1 and STAT2 activation is not modulated by IL-4, and (iii) activation of Janus kinases is not enhanced or prolonged by simultaneous stimulation with IFN-alpha and IL-4. Moreover, co-stimulation results in a selective increased STAT6/STAT2 association and an association between IFNAR/IL-4R components, suggesting that the IFNAR provides an additional STAT6 docking site via STAT2, leading to a more efficient dimerization/activation of STAT6 only. The co-stimulatory effect on STAT6 activation correlates with a cooperative increase in nuclear translocation, DNA binding, transcriptional activity, and mRNA expression of STAT6 target genes (IL-4Ralpha and IL-15Ralpha). In conclusion, we provide evidence that IFN-alpha both up- and down-regulates IL-4-mediated STAT6 signaling and thereby regulates the sensitivity to IL-4 in human T lymphocytes. Thus, our findings suggest that IFN-alpha has a complex regulatory role in adaptive immunity, which is different from the "classical" Th1 profile of IFN-gamma.

AB - Interferon (IFN)-alpha/beta is produced by virally infected cells and is believed to play an important role in early phases of the innate immune response. In addition, IFN-alpha/beta inhibits interleukin (IL)-4 signaling in B cells and monocytes, suggesting that IFN-alpha/beta (like IFN-gamma) is a Th1 cytokine. Here, we study cross-talk between IFN-alpha and IL-4 in human T cells. As expected, stimulation with IFN-alpha for 12-24 h inhibits IL-4 signaling. Surprisingly, however, IFN-alpha has the opposite effect on IL-4 signaling at earlier time points (up to 6 h). Thus, IFN-alpha enhances IL-4-mediated STAT6 activation in both CD4+ and CD8+ human T cells. The effect is specific because (i) another interferon, IFN-gamma, does not enhance IL-4-mediated STAT6 activation, (ii) IFN-alpha-mediated STAT1 and STAT2 activation is not modulated by IL-4, and (iii) activation of Janus kinases is not enhanced or prolonged by simultaneous stimulation with IFN-alpha and IL-4. Moreover, co-stimulation results in a selective increased STAT6/STAT2 association and an association between IFNAR/IL-4R components, suggesting that the IFNAR provides an additional STAT6 docking site via STAT2, leading to a more efficient dimerization/activation of STAT6 only. The co-stimulatory effect on STAT6 activation correlates with a cooperative increase in nuclear translocation, DNA binding, transcriptional activity, and mRNA expression of STAT6 target genes (IL-4Ralpha and IL-15Ralpha). In conclusion, we provide evidence that IFN-alpha both up- and down-regulates IL-4-mediated STAT6 signaling and thereby regulates the sensitivity to IL-4 in human T lymphocytes. Thus, our findings suggest that IFN-alpha has a complex regulatory role in adaptive immunity, which is different from the "classical" Th1 profile of IFN-gamma.

U2 - 10.1074/jbc.M310472200

DO - 10.1074/jbc.M310472200

M3 - Journal article

C2 - 14559900

VL - 279

SP - 169

EP - 176

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -

ID: 8544431